3-165829794-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000055.4(BCHE):c.1240C>T(p.Arg414Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
BCHE
NM_000055.4 missense
NM_000055.4 missense
Scores
14
3
2
Clinical Significance
Conservation
PhyloP100: 4.13
Genes affected
BCHE (HGNC:983): (butyrylcholinesterase) This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.981
PP5
Variant 3-165829794-G-A is Pathogenic according to our data. Variant chr3-165829794-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 551265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.1240C>T | p.Arg414Cys | missense_variant | 2/4 | ENST00000264381.8 | NP_000046.1 | |
BCHE | NR_137636.2 | n.1358C>T | non_coding_transcript_exon_variant | 2/5 | ||||
BCHE | NR_137635.2 | n.110+7520C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCHE | ENST00000264381.8 | c.1240C>T | p.Arg414Cys | missense_variant | 2/4 | 1 | NM_000055.4 | ENSP00000264381.3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250530Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135390
GnomAD3 exomes
AF:
AC:
10
AN:
250530
Hom.:
AF XY:
AC XY:
5
AN XY:
135390
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461642Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727110
GnomAD4 exome
AF:
AC:
27
AN:
1461642
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
727110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74196
GnomAD4 genome
AF:
AC:
2
AN:
151922
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Deficiency of butyrylcholinesterase Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 20, 2023 | Variant summary: BCHE c.1240C>T (p.Arg414Cys) results in a non-conservative amino acid change located in the Carboxylesterase, type B (IPR002018) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 250530 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in BCHE causing Deficiency Of Butyrylcholine Esterase (4e-05 vs 0.016), allowing no conclusion about variant significance. c.1240C>T has been reported in the literature in individuals affected with Deficiency Of Butyrylcholine Esterase (Whittington_2012, Yen_2003, On-Kei_2005). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrates reduced enzyme activity in a homozygous patient (Whittington_2012) and in recombinant cells (Brazzolotto_2021). The following publications have been ascertained in the context of this evaluation (PMID: 33024248, 15563885, 22378569, 12881446). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 28, 2017 | - - |
BCHE-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 18, 2022 | The BCHE c.1240C>T variant is predicted to result in the amino acid substitution p.Arg414Cys. This variant (referred to as p.Arg386Cys in the literature) was previously reported, also in the homozygous state, in a patient who presented with post-succinylcholine paralysis and severely reduced butyrylcholinesterase enzyme activity (Whittington et al. 2012. PubMed ID: 22378569). In vitro analysis of recombinant variant protein suggested that the p.Arg414Cys change results in retention of the variant protein in the endoplasmic reticulum (Brazzolotto et al. 2020. PubMed ID: 33024248). Additionally, this variant was also identified in the heterozygous state in an individual who presented with prolonged post-succinylcholine apnea (Yen et al. 2003. PubMed ID: 12881446). At PreventionGenetics, we previously identified this variant in the apparently homozygous state in an individual with suspected BCHE deficiency after an adverse reaction post-surgery (internal data). Taken together, we classify the c.1240C>T variant as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of disorder (P = 0.0083);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at